153 related articles for article (PubMed ID: 24362498)
1. Fractionated external beam radiotherapy of skull base metastases with cranial nerve involvement.
Dröge LH; Hinsche T; Canis M; Alt-Epping B; Hess CF; Wolff HA
Strahlenther Onkol; 2014 Feb; 190(2):199-203. PubMed ID: 24362498
[TBL] [Abstract][Full Text] [Related]
2. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].
Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966
[TBL] [Abstract][Full Text] [Related]
3. [Classification of Clinical Syndromes Associated with Skull-Base Metastasis in the MR Era].
Hayashi N; Mitsuya K; Deguchi S; Nakasu Y
No Shinkei Geka; 2018 Oct; 46(10):865-873. PubMed ID: 30369488
[TBL] [Abstract][Full Text] [Related]
4. Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy.
Lu TX; Mai WY; Teh BS; Hu YH; Lu HH; Chiu JK; Carpenter LS; Woo SY; Butler EB
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):589-98. PubMed ID: 11597797
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiotherapy using Novalis for skull base metastases developing with cranial nerve symptoms.
Mori Y; Hashizume C; Kobayashi T; Shibamoto Y; Kosaki K; Nagai A
J Neurooncol; 2010 Jun; 98(2):213-9. PubMed ID: 20405306
[TBL] [Abstract][Full Text] [Related]
6. Skull-base metastases.
Laigle-Donadey F; Taillibert S; Martin-Duverneuil N; Hildebrand J; Delattre JY
J Neurooncol; 2005 Oct; 75(1):63-9. PubMed ID: 16215817
[TBL] [Abstract][Full Text] [Related]
7. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
[TBL] [Abstract][Full Text] [Related]
8. Jugular foramen tumors: diagnosis and treatment.
Ramina R; Maniglia JJ; Fernandes YB; Paschoal JR; Pfeilsticker LN; Neto MC; Borges G
Neurosurg Focus; 2004 Aug; 17(2):E5. PubMed ID: 15329020
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas.
Minniti G; Clarke E; Cavallo L; Osti MF; Esposito V; Cantore G; Cappabianca P; Enrici RM
Radiat Oncol; 2011 Apr; 6():36. PubMed ID: 21486436
[TBL] [Abstract][Full Text] [Related]
11. Calvarial and skull base metastases: expanding the clinical utility of Gamma Knife surgery.
Kotecha R; Angelov L; Barnett GH; Reddy CA; Suh JH; Murphy ES; Neyman G; Chao ST
J Neurosurg; 2014 Dec; 121 Suppl():91-101. PubMed ID: 25434942
[TBL] [Abstract][Full Text] [Related]
12. Cranial nerve palsies in metastatic prostate cancer--results of base of skull radiotherapy.
O'Sullivan JM; Norman AR; McNair H; Dearnaley DP
Radiother Oncol; 2004 Jan; 70(1):87-90. PubMed ID: 15036857
[TBL] [Abstract][Full Text] [Related]
13. Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.
Combs SE; Salehi-Allameh B; Habermehl D; Kessel KA; Welzel T; Debus J
Head Neck; 2014 Jan; 36(1):22-7. PubMed ID: 23649985
[TBL] [Abstract][Full Text] [Related]
14. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
[TBL] [Abstract][Full Text] [Related]
15. Curative external beam radiotherapy for prostate carcinoma: results in 231 patients treated in Lyon.
Gerard JP; Xie C; Carrie C; Romestaing P; Pommier P; Mornex F; Clippe S; Sentenac I; Ginestet C
Aust N Z J Surg; 1999 Oct; 69(10):707-11. PubMed ID: 10527346
[TBL] [Abstract][Full Text] [Related]
16. Cranial nerve lesions due to base of the skull metastases in prostate carcinoma.
Ransom DT; Dinapoli RP; Richardson RL
Cancer; 1990 Feb; 65(3):586-9. PubMed ID: 2297648
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
18. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results.
Debus J; Wuendrich M; Pirzkall A; Hoess A; Schlegel W; Zuna I; Engenhart-Cabillic R; Wannenmacher M
J Clin Oncol; 2001 Aug; 19(15):3547-53. PubMed ID: 11481362
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated stereotactic radiation therapy in skull base meningiomas.
Navarria P; Pessina F; Cozzi L; Clerici E; Villa E; Ascolese AM; De Rose F; Comito T; Franzese C; D'Agostino G; Lobefalo F; Fogliata A; Reggiori G; Fornari M; Tomatis S; Bello L; Scorsetti M
J Neurooncol; 2015 Sep; 124(2):283-9. PubMed ID: 26040487
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study.
Holtzman AL; Rotondo RL; Rutenberg MS; Indelicato DJ; Mercado CE; Rao D; Tavanaiepour D; Morris CG; Louis D; Flampouri S; Mendenhall WM
J Neurooncol; 2019 May; 142(3):557-563. PubMed ID: 30827010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
